UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 23, 2023
QUALIS INNOVATIONS, INC.
(Exact name of registrant as specified in its charter)
Nevada | 333-260982 | 84-2488498 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
225 Wilmington West Chester Pike
Suite 200 # 145
Chadds Ford, Pennsylvania 19317
(Address of principal executive offices)
Registrant’s telephone number, including area code: Telephone: : (484) 483-2134
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
There were 8,475,950 shares of common stock $0.001 par value, issued and outstanding as of November 14, 2022 | QLIS | OTC Pink marketplace |
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On January 23, 2023, Dr. Robert Bilkovski, the Chief Scientific Officer of Qualis Innovations, Inc. (the “Company”), notified the Company of his decision to resign, effective immediately, from any and all offices he may hold with the Company, including Chief Scientific Officer of the Company. Dr. Bilkovsk.i’s resignation was to pursue other business opportunities and did not result from any disagreement with the Company, the Company’s Board of Directors, or the Company’s management on any matter relating to the Company’s operations, policies or practices.
Exhibit No | Description | |
1 | ||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
-2- |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
QUALIS INNOVATIONS, INC. | ||
By: | /s/ Jim Holt | |
Name: | Jim Holt | |
Date: | January 23, 2023 |
-3- |